Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis
Authors:
- Yusuke IsshikiYIYusuke Isshiki
- Motohiko OshimaMOMotohiko Oshima
- Naoya MimuraNMNaoya Mimura
- Kensuke KayamoriKKKensuke Kayamori
- Yurie Miyamoto-NagaiYMYurie Miyamoto-Nagai
- Masahide SekiMSMasahide Seki
- Yaeko Nakajima-TakagiYNYaeko Nakajima-Takagi
- Takashi KanamoriTKTakashi Kanamori
- Eisuke IwamotoEIEisuke Iwamoto
- Tomoya MutoTMTomoya Muto
- Shokichi TsukamotoSTShokichi Tsukamoto
- Yusuke TakedaYTYusuke Takeda
Open Access
- 24 October 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (20)
Abstract
POEMS syndrome is a rare monoclonal plasma cell disorder, with unique symptoms distinct from those of other plasma cell neoplasms, including high serum VEGF levels. Because the prospective isolation of POEMS clones has not yet been successful, their real nature remains unclear. Herein, we performed single-cell RNA-Seq of BM plasma cells from patients with POEMS syndrome and identified POEMS clones that had Ig λ light chain ( IGL ) sequences ( IGLV1-36 , -40 , -44 , and - 47 ) with amino acid changes specific to POEMS syndrome. The proportions of POEMS clones in plasma cells were markedly smaller than in patients with multiple myeloma (MM) and patients with monoclonal gammopathy of undetermined significance (MGUS). Single-cell transcriptomes revealed that POEMS clones were CD19 + , CD138 + , and MHC class II lo , which allowed for their prospective isolation. POEMS clones expressed significantly lower levels of c- MYC and CCND1 than MM clones, accounting for their small size. VEGF mRNA was not upregulated in POEMS clones, directly indicating that VEGF is not produced by POEMS clones. These results reveal unique features of POEMS clones and enhance our understanding of the pathogenesis of POEMS syndrome.Keywords
Funding Information
- the Ministry of Health, Labor, and Welfare of Japan and the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research [KAKENHI 16H06279 (PAGS),18K08338,19H05653,221S0002,)
- the Ministry of Health, Labor, and Welfare of Japan and the Japan Society for the Promotion of Science (19H05746])
This publication has 31 references indexed in Scilit:
- Characterization of immunoglobulin λ light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndromeAnnals of Hematology, 2012
- Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patientsBlood, 2011
- Multiple MyelomaNew England Journal of Medicine, 2011
- Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndromeBlood, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansionBlood, 2004
- Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implicationsBritish Journal of Haematology, 2003
- POEMS syndrome: definitions and long-term outcomeBlood, 2003
- The Crow‐Fukase syndromeNeurology, 1984
- Plasma Cell Dyscrasia with Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin ChangesMedicine, 1980